Director/PDMR Shareholding

GlaxoSmithKline PLC 01 July 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the directors' interests in the Ordinary Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 1 July 2005, the following non-executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company under the share allocation arrangements for non-executive Directors for the period of service from 1 April to 30 June 2005, as listed below. Non Executive Director Ordinary Shares American Depository Shares (ADS) Sir Christopher Gent 1,858.74 Mr Lawrence Culp 745.46 Sir Crispin Davis 1,486.99 Sir Deryck Maughan 745.46 Sir Ian Prosser 1,022.30 Dr Ronaldo Schmitz 669.14 Dr Lucy Shapiro 186.36 Sir Robert Wilson 464.68 The Company and the directors were informed of these allocations on 1 July 2005. This notification relates to transactions notified in accordance with Disclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 1 July 2005 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings